Corrigendum to “Long-term efficacy and safety of single-dose omalizumab in treating acute spontaneous urticaria” [Allerg Med 4 (2025) 100049]

Allergy Medicine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles